<DOC>
	<DOCNO>NCT01731275</DOCNO>
	<brief_summary>To evaluate safety , tolerability , pharmacokinetics pharmacodynamics single ascend dose ( SAD ) administration E6011 Japanese healthy volunteer .</brief_summary>
	<brief_title>A Phase 1 Single Dose Study E6011 Japanese Healthy Adult Male Subjects ( Study E6011-J081-001 )</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion ; 1 . Nonsmoking Japanese male subject age &gt; = 20 le 45 year 2 . BMI screen &gt; = 18.5 kg/m2 less 25.0 kg/m^2 3 . Males successful vasectomy female partner must agree practice highly effective contraception throughout study period . Exclusion criterion ; 1 . Has treat biologic product ( except immunoglobulin preparation ) 2 . Have receive immunoglobulin blood preparation within 6 month study drug administration 3 . Received inoculation within 4 week study drug administration 4 . Has history autoimmune disease immunodeficiency 5 . Has clinically significant angioedema , hematemesis , anal hemorrhage , hemoptysis 6 . Has history acute myocardial infarction , cerebral infarction , cerebral hemorrhage , arteriosclerosis obliterate 7 . With gross hematuria , occult bleed urine ( &gt; =1+ ) urine protein ( &gt; =1+ ) , either ( &gt; =2+ ) screen 8 . Has clinically significant vasculitis ( e.g. , multiple mononeuropathy ) 9 . Known positive human immunodeficiency virus ( HIV antigen antibody ) , hepatitis B virus surface antigen ( HBs antigen ) , hepatitis B virus surface antibody ( HBs antibody ) , hepatitis B virus ( HBV ) DNA , hepatitis C virus ( HCV ) antibody , syphilis serology test 10 . Known positive human Tcell lymphotropic virus type 1 ( HTVL1 ) antibody screen 11 . Known positive QuantiFERONTB Gold Test 12 . Treated ethical drug ( ) within 4 week study drug administration ( except disinfectant , eye drop ) 13 . Treated nonprescription drug ( ) within 2 week study drug administration ( except disinfectant , eye drop ) 14 . Has participate another clinical trial receive investigational drug device within 6 month study drug administration 15 . Received blood transfusion within 1 year , 400 mL whole blood donation within 12 week , 200 mL whole blood donation within 4 week , blood constituent donation within 2 week study drug administration .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>anti-E6011 antibody</keyword>
</DOC>